MEM — Memphasys Income Statement
0.000.00%
- AU$8.86m
- AU$12.63m
- AU$0.06m
Annual income statement for Memphasys, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0.027 | 0.015 | 0.06 |
Cost of Revenue | |||||
Gross Profit | — | — | 0.008 | 0.009 | 0.002 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1.13 | 1.49 | 1.59 | 3.02 | 4.2 |
Operating Profit | -1.13 | -1.49 | -1.57 | -3.01 | -4.14 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.13 | -1.49 | -2.08 | -3.4 | -4.44 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.13 | -1.49 | -2.08 | -3.4 | -4.44 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.13 | -1.49 | -2.08 | -3.4 | -4.44 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.13 | -1.49 | -2.08 | -3.4 | -4.44 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.001 | -0.002 | -0.002 | -0.003 | -0.003 |